Birmingham Hematology and Oncology Associates, LLC d.b.a Alabama Oncology

500 Office Park Drive
Birmingham, Alabama 35223

We've found

1 trials

at this facility

A Study of Parsaclisib in Combination With Ruxolitinib in Subjects With Myelofibrosis

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Birmingham, AL

Use our guide to learn which trials are right for you!